Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Pharma-Bio Serv (PBSV) Operating Margin (2016 - 2026)

Pharma-Bio Serv's Operating Margin history spans 16 years, with the latest figure at 4.12% for Q1 2026.

  • For Q1 2026, Operating Margin fell 39.0% year-over-year to 4.12%; the TTM value through Jan 2026 reached 7.25%, up 255.0%, while the annual FY2025 figure was 7.08%, 646.0% up from the prior year.
  • Operating Margin reached 4.12% in Q1 2026 per PBSV's latest filing, up from 6.2% in the prior quarter.
  • In the past five years, Operating Margin ranged from a high of 10.06% in Q3 2023 to a low of 18.41% in Q1 2024.
  • Average Operating Margin over 5 years is 2.31%, with a median of 3.73% recorded in 2025.
  • Peak YoY movement for Operating Margin: soared 8936bps in 2022, then tumbled -2617bps in 2024.
  • A 5-year view of Operating Margin shows it stood at 3.64% in 2022, then crashed by -139bps to 1.44% in 2023, then plummeted by -359bps to 6.61% in 2024, then grew by 6bps to 6.2% in 2025, then skyrocketed by 34bps to 4.12% in 2026.
  • Per Business Quant, the three most recent readings for PBSV's Operating Margin are 4.12% (Q1 2026), 6.2% (Q4 2025), and 15.99% (Q3 2025).